Everolimus treatment in advanced solid tumors: a personal view

Por Pusceddu, Sara, Indini, Alice, Procopio, Giuseppe
Publicado no Future Sci OA (2015)

Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert

Por Altavilla, Amelia, Iacovelli, Roberto, Procopio, Giuseppe, Cortesi, Enrico
Publicado em 2012

Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

Por Grassi, Paolo, Verzoni, Elena, Mennitto, Alessia, Procopio, Giuseppe
Publicado no Transl Androl Urol (2016)

First line treatment of metastatic renal cell carcinoma: Two standards with different toxicity profile

Por Iacovelli, Roberto, Verzoni, Elena, De Braud, Filippo, Procopio, Giuseppe
Publicado em 2014

Study design and clinical evidence in mRCC: Can we save axitinib as a first-line therapy?

Por Iacovelli, Roberto, Verzoni, Elena, De Braud, Filippo Maria, Procopio, Giuseppe
Publicado em 2014

Predicting Molecular Models: Where Are We Going?

Por Ratta, Raffaele, Verzoni, Elena, Grassi, Paolo, Niger, Monica, Procopio, Giuseppe
Publicado no EBioMedicine (2015)

Response to Targeted Therapy in Urachal Adenocarcinoma

Por Testa, Isabella, Verzoni, Elena, Grassi, Paolo, Colecchia, Maurizio, Panzone, Filomena, Procopio, Giuseppe
Publicado no Rare Tumors (2014)

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

Por Mennitto, Alessia, Grassi, Paolo, Ratta, Raffaele, Verzoni, Elena, Prisciandaro, Michele, Procopio, Giuseppe
Publicado no Ther Adv Urol (2016)

Experience with sorafenib in the treatment of advanced renal cell carcinoma

Por Procopio, Giuseppe, Verzoni, Elena, Testa, Isabella, Nicolai, Nicola, Salvioni, Roberto, DeBraud, Filippo
Publicado em 2012

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib

Por Grassi, Paolo, Verzoni, Elena, Porcu, Luca, Iacovelli, Roberto, de Braud, Filippo, Procopio, Giuseppe
Publicado no Ther Adv Urol (2015)

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Por Grassi, Paolo, Verzoni, Elena, Ratta, Raffaele, Mennitto, Alessia, de Braud, Filippo, Procopio, Giuseppe
Publicado no Drug Des Devel Ther (2016)

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

Por Verzoni, Elena, Grassi, Paolo, Ratta, Raffaele, Niger, Monica, De Braud, Filippo, Valdagni, Riccardo, Procopio, Giuseppe
Publicado no Ther Adv Med Oncol (2016)

Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant

Por Altavilla, Amelia, Iacovelli, Roberto, Procopio, Giuseppe, Alesini, Daniele, Risi, Emanuela, Campennì, Giuseppe Maria, Palazzo, Antonella, Cortesi, Enrico
Publicado em 2012

Targeted treatments in advanced renal cell carcinoma: focus on axitinib

Por Verzoni, Elena, Grassi, Paolo, Testa, Isabella, Iacovelli, Roberto, Biondani, Pamela, Garanzini, Enrico, De Braud, Filippo, Procopio, Giuseppe
Publicado em 2014

Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

Por Iacovelli, Roberto, Palazzo, Antonella, Procopio, Giuseppe, Santoni, Matteo, Trenta, Patrizia, De Benedetto, Angelina, Mezi, Silvia, Cortesi, Enrico
Publicado em 2014

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma

Por Zanardi, Elisa, Verzoni, Elena, Grassi, Paolo, Necchi, Andrea, Giannatempo, Patrizia, Raggi, Daniele, De Braud, Filippo, Procopio, Giuseppe
Publicado no Ther Adv Urol (2015)

Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib

Por Iacovelli, Roberto, Cartenì, Giacomo, Milella, Michele, Berardi, Rossana, Di Lorenzo, Giuseppe, Verzoni, Elena, Rizzo, Mimma, Santoni, Matteo, Procopio, Giuseppe
Publicado em 2014

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

Por Pusceddu, Sara, Verzoni, Elena, Prinzi, Natialie, Mennitto, Alessia, Femia, Daniela, Grassi, Paolo, Concas, Laura, Vernieri, Claudio, Lo Russo, Giuseppe, Procopio, Giuseppe
Publicado no Ther Adv Med Oncol (2017)

Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma

Por Iacovelli, Roberto, Santini, Daniele, Rizzo, Mimma, Felici, Alessandra, Santoni, Matteo, Verzoni, Elena, Masini, Cristina, Massari, Francesco, Calvani, Nicola, Mosca, Alessandra, Procopio, Giuseppe
Publicado no Can Urol Assoc J (2015)

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

Por Grassi, Paolo, Doucet, Ludovic, Giglione, Palma, Grünwald, Viktor, Melichar, Bohuslav, Galli, Luca, De Giorgi, Ugo, Sabbatini, Roberto, Ortega, Cinzia, Santoni, Matteo, Bamias, Aristotelis, Verzoni, Elena, Derosa, Lisa, Studentova, Hana, Pacifici, Monica, Coppa, Jorgelina, Mazzaferro, Vincenzo, de Braud, Filippo, Porta, Camillo, Escudier, Bernard, Procopio, Giuseppe
Publicado no PLoS One (2016)